Table 3.

RAMs for VTE and bleeding

Risk factorsOR (95% CI) from systematic reviewβ coefficients (log OR)SEContribution to overall risk, %
VTE 
 Age >60 y 1.34 (1.17-1.55) 0.29 0.07 3.6 
 Previous VTE 6.08 (3.71-9.97) 1.81 0.25 22.7 
 Acute infections 1.48 (1.16-1.89) 0.39 0.12 4.9 
 Immobility 3.17 (2.18-4.62) 1.15 0.19 14.4 
 Acute paresis 2.97 (1.20-7.36) 1.09 0.46 13.6 
 Active malignancy 2.65 (1.79-3.91) 0.98 0.20 12.3 
 Critical illness 1.65 (1.39-1.95) 0.50 0.09 6.3 
 Known history of thrombophilia 5.88 (2.80-12.35) 1.77 0.38 22.2 
 Total  7.98   
Bleeding 
 Age ≥65 y 1.95 (1.59-2.38) 0.67 0.10 12.3 
 Renal failure 1.43 (1.06-1.93) 0.36 0.15 6.6 
 Thrombocytopenia 1.79 (0.97-3.29) 0.58 0.31 10.7 
 Active gastroduodenal ulcers 2.74 (1.42-5.26) 1.01 0.34 18.6 
 Hepatic disease 1.53 (1.09-2.15) 0.43 0.17 7.9 
 Recent bleeding 5.15 (2.45-10.81) 1.64 0.38 30.2 
 Critical illness 2.10 (1.42-3.11) 0.74 0.20 13.7 
 Total  5.43   
Risk factorsOR (95% CI) from systematic reviewβ coefficients (log OR)SEContribution to overall risk, %
VTE 
 Age >60 y 1.34 (1.17-1.55) 0.29 0.07 3.6 
 Previous VTE 6.08 (3.71-9.97) 1.81 0.25 22.7 
 Acute infections 1.48 (1.16-1.89) 0.39 0.12 4.9 
 Immobility 3.17 (2.18-4.62) 1.15 0.19 14.4 
 Acute paresis 2.97 (1.20-7.36) 1.09 0.46 13.6 
 Active malignancy 2.65 (1.79-3.91) 0.98 0.20 12.3 
 Critical illness 1.65 (1.39-1.95) 0.50 0.09 6.3 
 Known history of thrombophilia 5.88 (2.80-12.35) 1.77 0.38 22.2 
 Total  7.98   
Bleeding 
 Age ≥65 y 1.95 (1.59-2.38) 0.67 0.10 12.3 
 Renal failure 1.43 (1.06-1.93) 0.36 0.15 6.6 
 Thrombocytopenia 1.79 (0.97-3.29) 0.58 0.31 10.7 
 Active gastroduodenal ulcers 2.74 (1.42-5.26) 1.01 0.34 18.6 
 Hepatic disease 1.53 (1.09-2.15) 0.43 0.17 7.9 
 Recent bleeding 5.15 (2.45-10.81) 1.64 0.38 30.2 
 Critical illness 2.10 (1.42-3.11) 0.74 0.20 13.7 
 Total  5.43   

SE, standard error.

View Large
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal